Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
Chromocell Therapeutics Corp (CHRO) Stock Price & Analysis
7 Followers
CHRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.21 - $6.00
Previous Close$1.75
Volume49.08K
Average Volume (3M)25.10K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$96.39K
Total Debt (Recent Filing)$1.27M
Price to Earnings (P/E)-1.1
Beta2.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.54
Shares Outstanding5,766,704
10 Day Avg. Volume24,431
30 Day Avg. Volume25,100
Standard Deviation0.00831
R-Squared1.00
Alpha-0.31
Financial Highlights & Ratios
Price to Book (P/B)-1.71
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Chromocell Therapeutics Corp News
PremiumCompany Announcements
Chromocell Announces New Eye Pain Treatment InitiativePremiumCompany Announcements
Chromocell Therapeutics Appoints Experienced CEO Francis Knuettel IIOwnership Overview
9.53% Insiders
0.00% Mutual Funds
4.37% Other Institutional Investors
86.10% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CHRO FAQ
What was Chromocell Therapeutics Corp’s price range in the past 12 months?
Chromocell Therapeutics Corp lowest stock price was $1.21 and its highest was $6.00 in the past 12 months.
What is Chromocell Therapeutics Corp’s market cap?
Currently, no data Available
When is Chromocell Therapeutics Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Chromocell Therapeutics Corp’s earnings last quarter?
Currently, no data Available
Is Chromocell Therapeutics Corp overvalued?
According to Wall Street analysts Chromocell Therapeutics Corp’s price is currently Overvalued.
Does Chromocell Therapeutics Corp pay dividends?
Chromocell Therapeutics Corp does not currently pay dividends.
What is Chromocell Therapeutics Corp’s EPS estimate?
Chromocell Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chromocell Therapeutics Corp have?
Chromocell Therapeutics Corp has 5,767,525 shares outstanding.
What happened to Chromocell Therapeutics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chromocell Therapeutics Corp?
Currently, no hedge funds are holding shares in CHRO
---
Chromocell Therapeutics Corp Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $239.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8194.02%
Trailing 12-Months
Company Description
Chromocell Therapeutics Corp
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
---
Technical Analysis
---